Ophthalmic toxicity following paclitaxel infusion.
Hofstra
L S
LS
de Vries
E G
EG
Willemse
P H
PH
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel